Next Article in Journal
Respiratory Distress in the Newborn with Primary Ciliary Dyskinesia
Next Article in Special Issue
Long-Term Outcomes and the Post-Intensive Care Syndrome in Critically Ill Children: A North American Perspective
Previous Article in Journal
The Complexities Associated with Caring for Hospitalised Infants with Neonatal Abstinence Syndrome: The Perspectives of Nurses and Midwives
Previous Article in Special Issue
Understanding Suicide in Our Community through the Lens of the Pediatric ICU: An Epidemiological Review (2011–2017) of One Midwestern City in the US
Article

The Feasibility of Studying Metabolites in PICU Multi-Organ Dysfunction Syndrome Patients over an 8-Day Course Using an Untargeted Approach

1
Pediatric Critical Care Unit, Helen DeVos Children’s Hospital, 100 Michigan Street NE, Grand Rapids, MI 49503, USA
2
Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Life Sciences Building, 1355 Bogue Street, East Lansing, MI 48824, USA
3
Spectrum Health, 100 Michigan Street NE, Grand Rapids, MI 49503, USA
4
College of Human Medicine, Michigan State University, 15 Michigan Street NE, Grand Rapids, MI 49503, USA
5
Department of Pharmacology and Toxicology, Michigan State University, 1355 Bogue Street, East Lansing, MI 48824, USA
6
Department of Physiology, Collaborative Mass Spectrometry Core, Michigan State University, 578 S. Shaw Ln. Chemistry Building, East Lansing, MI 48824, USA
*
Author to whom correspondence should be addressed.
Contributed equally to this work.
Academic Editor: Sari A. Acra
Received: 3 December 2020 / Revised: 7 February 2021 / Accepted: 11 February 2021 / Published: 18 February 2021
(This article belongs to the Special Issue Advances in Pediatric Critical Care)
Metabolites are generated from critical biological functions and metabolism. This pediatric study reviewed plasma metabolites in patients suffering from multi-organ dysfunction syndrome (MODS) in the pediatric intensive care unit (PICU) using an untargeted metabolomics approach. Patients meeting the criteria for MODS were screened for eligibility and consented (n = 24), and blood samples were collected at baseline, 72 h, and 8 days; control patients (n = 4) presented for routine sedation in an outpatient setting. A subset of MODS patients (n = 8) required additional support with veno-atrial extracorporeal membrane oxygenation (VA-ECMO) therapy. Metabolites from thawed blood plasma were determined from ion pairing reversed-phase liquid chromatography–mass spectrometry (LC-MS) analysis. Chromatographic peak alignment, identification, relative quantitation, and statistical and bioinformatics evaluation were performed using MAVEN and MetaboAnalyst 4.0. Metabolite analysis revealed 115 peaks per sample. From the partial least squares-discriminant analysis (PLS-DA) with variance of importance (VIP) scores above ≥2.0, 7 dynamic metabolites emerged over the three time points: tauro-chenodeoxycholic acid (TCDCA), hexose, p-hydroxybenzoate, hydroxyphenylacetic acid (HPLA), 2_3-dihydroxybenzoic acid, 2-keto-isovalerate, and deoxyribose phosphate. After Bonferroni adjustment for repeated measures, hexose and p-hydroxybenzoate were significant at one time point or more. Kendall’s tau-b test was used for internal validation of creatinine. Metabolites may be benign or significant in describing a patient’s pathophysiology and require operator interpretation. View Full-Text
Keywords: blood plasma; extracorporeal membrane oxygenation; metabolites; multiple organ dysfunction syndrome; pediatric intensive care unit; liquid chromatography–mass spectrometry blood plasma; extracorporeal membrane oxygenation; metabolites; multiple organ dysfunction syndrome; pediatric intensive care unit; liquid chromatography–mass spectrometry
Show Figures

Figure 1

MDPI and ACS Style

Leimanis-Laurens, M.; Gil, D.; Kampfschulte, A.; Krohn, C.; Prentice, E.; Sanfilippo, D.; Prokop, J.W.; Lydic, T.A.; Rajasekaran, S. The Feasibility of Studying Metabolites in PICU Multi-Organ Dysfunction Syndrome Patients over an 8-Day Course Using an Untargeted Approach. Children 2021, 8, 151. https://0-doi-org.brum.beds.ac.uk/10.3390/children8020151

AMA Style

Leimanis-Laurens M, Gil D, Kampfschulte A, Krohn C, Prentice E, Sanfilippo D, Prokop JW, Lydic TA, Rajasekaran S. The Feasibility of Studying Metabolites in PICU Multi-Organ Dysfunction Syndrome Patients over an 8-Day Course Using an Untargeted Approach. Children. 2021; 8(2):151. https://0-doi-org.brum.beds.ac.uk/10.3390/children8020151

Chicago/Turabian Style

Leimanis-Laurens, Mara, Danny Gil, Andrew Kampfschulte, Claire Krohn, Elizabeth Prentice, Dominic Sanfilippo, Jeremy W. Prokop, Todd A. Lydic, and Surender Rajasekaran. 2021. "The Feasibility of Studying Metabolites in PICU Multi-Organ Dysfunction Syndrome Patients over an 8-Day Course Using an Untargeted Approach" Children 8, no. 2: 151. https://0-doi-org.brum.beds.ac.uk/10.3390/children8020151

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop